CD8A and melanoma: These results are consistent with experimentally observed results of increased survival and cytokine production in CD8 T cells from healthy donors39 and melanoma tumor-infilatrating CD8 lymphocytes40 when exposed to 4-1BB costimulatory ligand or agonist.